All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.

Kennedy Jr. made it clear in his first US Senate confirmation hearing that his quest to reduce chronic disease would entail a closer look at the food industry, namely manufacturers of packaged foods.

Here’s what to know about ultra-processed foods, and how Kennedy has said he plans to shape the U.S. food system.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Robert F. Kennedy Jr. will have the second of two confirmation hearings for his Health and Human Services Secretary nomination Thursday.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Robert F. Kennedy, Jr., President Trump's nominee to serve as Secretary of Health and Human Services testifies during a ...